131 related articles for article (PubMed ID: 8779622)
41. Intellectual performance of children with maple syrup urine disease.
Hilliges C; Awiszus D; Wendel U
Eur J Pediatr; 1993 Feb; 152(2):144-7. PubMed ID: 8444223
[TBL] [Abstract][Full Text] [Related]
42. L-Carnitine supplementation decreases DNA damage in treated MSUD patients.
Mescka CP; Guerreiro G; Hammerschmidt T; Faverzani J; de Moura Coelho D; Mandredini V; Wayhs CA; Wajner M; Dutra-Filho CS; Vargas CR
Mutat Res; 2015 May; 775():43-7. PubMed ID: 25867118
[TBL] [Abstract][Full Text] [Related]
43. [Maple syrup urine disease of neonates: report of two cases and review of literature].
Chen Z; Luo F; Wu XJ; Shi LP
Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):680-4. PubMed ID: 21092528
[TBL] [Abstract][Full Text] [Related]
44. Odimet
Sánchez-Pintos P; Camba-Garea MJ; López-Pardo BM; Couce ML
Nutrients; 2024 Jan; 16(3):. PubMed ID: 38337708
[TBL] [Abstract][Full Text] [Related]
45. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
[TBL] [Abstract][Full Text] [Related]
46. Correction of hyperleucinemia in MSUD patients on leucine-free dietary therapy.
Scott AI; Cusmano-Ozog K; Enns GM; Cowan TM
Mol Genet Metab; 2017 Dec; 122(4):156-159. PubMed ID: 29032949
[TBL] [Abstract][Full Text] [Related]
47. Development of newborn screening connect (NBS connect): a self-reported patient registry and its role in improvement of care for patients with inherited metabolic disorders.
Osara Y; Coakley K; Devarajan A; Singh RH
Orphanet J Rare Dis; 2017 Jul; 12(1):132. PubMed ID: 28724394
[TBL] [Abstract][Full Text] [Related]
48. Differential diagnosis and treatment of hyperphenylalaninaemia.
Bickel H
Prog Clin Biol Res; 1985; 177():93-107. PubMed ID: 4011611
[No Abstract] [Full Text] [Related]
49. Computed tomography in maple syrup urine disease.
Taccone A; Schiaffino MC; Cerone R; Fondelli MP; Romano C
Eur J Radiol; 1992; 14(3):207-12. PubMed ID: 1563430
[TBL] [Abstract][Full Text] [Related]
50. Eleven novel mutations of the BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease in the Chinese population: Report on eight cases.
Li X; Ding Y; Liu Y; Ma Y; Song J; Wang Q; Li M; Qin Y; Yang Y
Eur J Med Genet; 2015 Nov; 58(11):617-23. PubMed ID: 26453840
[TBL] [Abstract][Full Text] [Related]
51. Dietary management of inborn errors of metabolism.
Kabra M
Indian J Pediatr; 2002 May; 69(5):421-6. PubMed ID: 12061677
[TBL] [Abstract][Full Text] [Related]
52. Tailoring of the diet for the individual in maple syrup urine disease: long-term home dietary treatment of an adult patient with MSUD by monitoring of daily intake with a personal computer. A case report.
Lie IE; Haugstad S; Holm H
Hum Nutr Appl Nutr; 1985 Apr; 39(2):130-6. PubMed ID: 3839494
[TBL] [Abstract][Full Text] [Related]
53. Inborn errors of metabolic diseases in Malaysia: a preliminary report of maple syrup urine diseases for 1993.
Zakiah I; Ashikin YN; Aisiah SM; Ismail HI
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():134-6. PubMed ID: 8629092
[TBL] [Abstract][Full Text] [Related]
54. Neonatal case of classic maple syrup urine disease: usefulness of (1) H-MRS in early diagnosis.
Sato T; Muroya K; Hanakawa J; Asakura Y; Aida N; Tomiyasu M; Tajima G; Hasegawa T; Adachi M
Pediatr Int; 2014 Feb; 56(1):112-5. PubMed ID: 24548198
[TBL] [Abstract][Full Text] [Related]
55. Diagnosis of disorders in amino acid methabolism by chemical ionization mass spectrometry.
Issachar D; Yinon J
Clin Chim Acta; 1976 Dec; 73(2):307-14. PubMed ID: 1000850
[TBL] [Abstract][Full Text] [Related]
56. Sugar nucleotide concentrations in red blood cells of patients on protein- and lactose-limited diets: effect of galactose supplementation.
Gibson JB; Berry GT; Palmieri MJ; Reynolds RA; Mazur AT; Segal S
Am J Clin Nutr; 1996 May; 63(5):704-8. PubMed ID: 8615352
[TBL] [Abstract][Full Text] [Related]
57. Acidosis associated with dietotherapy of maple syrup urine disease.
Foreman JW; Yudkoff M; Berry G; Segal S
J Pediatr; 1980 Jan; 96(1):62-4. PubMed ID: 7350316
[No Abstract] [Full Text] [Related]
58. Plasma amino acid analyses in two cases of maple syrup urine disease.
Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
[TBL] [Abstract][Full Text] [Related]
59. Maple syrup urine disease: report of two cases.
Yeung CY; Lin SP; Kao HA; Shen EY; Lee HC; Lin CH; Hsiao KJ
J Formos Med Assoc; 1993 Aug; 92(8):765-8. PubMed ID: 7904856
[TBL] [Abstract][Full Text] [Related]
60. Treatment of acute decompensation of maple syrup urine disease in adult patients with a new parenteral amino-acid mixture.
Servais A; Arnoux JB; Lamy C; Hummel A; Vittoz N; Katerinis I; Bazzaoui V; Dubois S; Broissand C; Husson MC; Berleur MP; Rabier D; Ottolenghi C; Valayannopoulos V; de Lonlay P
J Inherit Metab Dis; 2013 Nov; 36(6):939-44. PubMed ID: 23250513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
